Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$0.7 - $1.4 $1,194 - $2,388
-1,706 Reduced 83.14%
346 $0
Q1 2022

May 10, 2022

BUY
$0.63 - $1.59 $1,292 - $3,262
2,052 New
2,052 $3,000
Q4 2021

Feb 11, 2022

SELL
$1.27 - $2.42 $1,375 - $2,620
-1,083 Closed
0 $0
Q3 2021

Nov 08, 2021

SELL
$2.15 - $3.82 $23,297 - $41,393
-10,836 Reduced 90.91%
1,083 $2,000
Q2 2021

Aug 09, 2021

BUY
$2.89 - $4.45 $673 - $1,036
233 Added 1.99%
11,919 $45,000
Q1 2021

Apr 28, 2021

BUY
$2.9 - $4.09 $32,662 - $46,065
11,263 Added 2662.65%
11,686 $39,000
Q4 2020

Feb 09, 2021

SELL
$3.38 - $5.14 $32,552 - $49,503
-9,631 Reduced 95.79%
423 $1,000
Q3 2020

Nov 02, 2020

BUY
$2.99 - $4.9 $28,727 - $47,079
9,608 Added 2154.26%
10,054 $40,000
Q2 2020

Aug 11, 2020

SELL
$2.11 - $3.38 $1,367 - $2,190
-648 Reduced 59.23%
446 $2,000
Q1 2020

May 15, 2020

BUY
$1.83 - $3.45 $243 - $458
133 Added 13.84%
1,094 $3,000
Q4 2019

Feb 13, 2020

BUY
$3.5 - $10.35 $2,649 - $7,834
757 Added 371.08%
961 $3,000
Q3 2019

Oct 17, 2019

BUY
$7.03 - $9.7 $1,434 - $1,978
204 New
204 $2,000
Q2 2019

Aug 05, 2019

SELL
$7.36 - $11.26 $1,133 - $1,734
-154 Closed
0 $0
Q1 2019

Apr 16, 2019

SELL
$9.08 - $11.84 $5,366 - $6,997
-591 Reduced 79.33%
154 $2,000
Q4 2018

Jan 17, 2019

SELL
$6.39 - $16.99 $41,209 - $109,568
-6,449 Reduced 89.64%
745 $7,000
Q3 2018

Nov 02, 2018

BUY
$16.52 - $24.82 $28,843 - $43,335
1,746 Added 32.05%
7,194 $0
Q2 2018

Jul 24, 2018

BUY
$14.31 - $21.75 $44,690 - $67,925
3,123 Added 134.32%
5,448 $0
Q1 2018

May 03, 2018

BUY
$16.09 - $23.07 $4,247 - $6,090
264 Added 12.81%
2,325 $38,000
Q4 2017

Feb 02, 2018

BUY
$13.36 - $20.73 $16,272 - $25,249
1,218 Added 144.48%
2,061 $39,000
Q3 2017

Oct 20, 2017

BUY
$8.75 - $14.07 $7,376 - $11,861
843
843 $12,000

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.